BioHealth News Archive
Meet the BHI Analyst Team at the BioHealth Capital Region Investment Conference
This September 19th, the BioHealth Capital Region Investment Conference will once again serve as a premier gathering for the biopharma sector, uniting a dynamic…
Read More
Key Insights from Wilson Sonsini’s Entrepreneurs Report: 1H 2024
Wilson Sonsini's Entrepreneurs Report for the first half of 2024 is now available, offering critical insights into the current private company financing landscape. Valuations…
Read More
Hopkins Team Awarded Up To $20.9 Million in ARPA-H Funding to Further Tumor-Removal Research
A Whiting School-led interinstitutional research team will develop a novel photoacoustic endoscope and fluorescent contrast agent to ensure total tumor removal and preservation of…
Read More
WBJ: Virginia Tech taps D.C. incubator leader Sally Allain for new role
By Sara Gilgore – Staff Reporter, Washington Business Journal Aug 21, 2024 - Sally Allain, the inaugural head of Johnson & Johnson Innovation’s D.C.…
Read More
Falls Church’s Retension Pharmaceuticals Closes $10.4 Million Oversubscribed Series A to Fund Clinical Trials for Patients Suffering from Resistant and Uncontrolled Hypertension
FALLS CHURCH, Va.--(BUSINESS WIRE)--Retension Pharmaceuticals, Inc. is pleased to announce the successful closing of its Series A $10.4 million financing round to initiate a well-powered…
Read More
Explore the World of Technology Transfer and Commercialization with the Technology Transfer Society – Washington D.C. Chapter
The Technology Transfer Society – Washington D.C. Chapter is excited to announce its Fall 2024 course, "Introduction to Technology Transfer and Commercialization," offered in…
Read More
UVA Engineering Professor’s $600,000 Grant Set to Innovate Pediatric Brain Tumor Treatment
Natasha Sheybani, assistant professor of biomedical engineering at the University of Virginia School of Engineering, will collaborate with researchers at Children’s National Hospital to…
Read More
OS Therapies Accepted Into Johnson & Johnson Innovation – JLABS
ROCKVILLE, Md.--(BUSINESS WIRE)--OS Therapies (NYSE American: OSTX) (“OS Therapies” or “the Company”), an ADC and Immunotherapy research and clinical-stage biopharmaceutical company, today announced that it…
Read More
Women In Bio (WIB) Excited to Participate in the 10th Annual BioHealth Capital Region Forum
Women In Bio (WIB) will be well-represented at the 10th Annual BioHealth Capital Region Forum on September 17th and 18th, 2024, at US Pharmacopeia…
Read More
AURP’s BIO Health Caucus Sponsors 10th Annual BioHealth Capital Region Forum
AURP and its BIO Health Caucus have sponsored the 10th Annual BioHealth Capital Region Forum (Sept 17-18) at US Pharmacopeia in Rockville, MD. Serving…
Read More
Final Week to Apply! Deadline August 30th for the 9th Annual Crab Trap Competition
This is your last chance to apply for this year’s Crab Trap Competition, taking place on September 18th, 2024, during BioHealth Capital Region Week…
Read More
AstraZeneca’s Imfinzi approved in the US for the treatment of resectable non-small cell lung cancer before and after surgery
Based on AEGEAN Phase III trial results which showed Imfinzi-based regimen reduced the risk of recurrence, progression or death by 32% vs. neoadjuvant chemotherapy…
Read More
Axios:Venture capitalists move toward “pay to play”
Venture capitalists are inserting a record number of "pay to play" provisions into term sheets, according to new data from law firm Cooley. Why it matters: This…
Read More
Biden-Harris Administration Announces $150 Million from ARPA-H to Deliver Progress on Biden Cancer Moonshot Goals and Improve Health Outcomes
More than two years ago, President Joe Biden and First Lady Jill Biden reignited the Cancer Moonshot with the goals of reducing the cancer…
Read More
TEDCO Announces Kim Mozingo’s Promotion to Vice President, Federal Programs
COLUMBIA, Md., (August 13, 2024) — TEDCO, Maryland’s economic engine for technology companies, is pleased to announce the promotion of Kim Mozingo to vice…
Read More